Novartis AG
FUSED TRICYCLIC PYRIDAZINONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS
Last updated:
Abstract:
The invention provides compounds of Formula (I): ##STR00001## as further described herein, as well as pharmaceutical compositions comprising such compounds, and methods to use the compounds and pharmaceutical compositions for treatment of certain viral disorders, including influenza.
Status:
Application
Type:
Utility
Filling date:
25 Aug 2017
Issue date:
23 Apr 2020